Transpire Bio signs with Recipharm for inhaled medicine development

Transpire Bio signs with Recipharm for inhaled medicine development

Source: 
European Pharmaceutical Review
snippet: 

Transpire Bio and Recipharm have signed a definitive agreement for the development of TRB-1 and TRB-2 – two inhaled medicines for the treatment of asthma and Chronic Obstructive Pulmonary Disease (COPD).